USFDA inspection at Aurobindo Pharma's Unit IV
Updated: February 21, 2020 07:06 PM IST
The Company received a communication that the inspection conducted by the US Food and Drug Administration (USFDA) at our aforesaid Unit IV, from November 4, 2019, to November 13, 2019, is still open and under review